NextCODE Health

About:

NextCODE is a genomic information company using sequence data to improve health for people around the world.

Twitter/X: NextCODE

Top Investors: Polaris Partners, ARCH Venture Partners

Description:

NextCODE Health is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. Using technology developed over more than 16 years at deCODE genetics, we are enabling the widespread incorporation of genome sequence data into patient diagnosis and care. NextCODE was acquired by WuXi AppTec in 2015 and was renamed WuXi NextCODE before rebranding to [Genuity Science](/organization/genuity-science) in 2020.

Total Funding Amount:

$15M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)nextcode.com

Founders:

Hannes Thor Smárason, Jeffrey Gulcher

Number of Employees:

11-50

Last Funding Date:

2013-10-25

IPO Status:

Private

Industries: